Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

67.00
+0.93001.41%
Post-market: 67.000.00000.00%16:37 EST
Volume:662.52K
Turnover:44.40M
Market Cap:6.40B
PE:25.57
High:67.36
Open:65.99
Low:65.90
Close:66.07
52wk High:89.66
52wk Low:64.02
Shares:95.51M
Float Shares:60.41M
Volume Ratio:1.30
T/O Rate:1.10%
Dividend:1.35
Dividend Rate:2.01%
EPS(TTM):2.62
EPS(LYR):2.66
ROE:10.02%
ROA:5.52%
PB:2.44
PE(LYR):25.19

Loading ...

How Dolby’s New Home and In‑Car Atmos Experiences Could Reshape the DLB Competitive Narrative

Simply Wall St.
·
Yesterday

Dolby EVP Mark Andrew Sherman Reports Sale of Common Shares

Reuters
·
Dec 04

Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

GlobeNewswire
·
Dec 03

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

GlobeNewswire
·
Dec 02

Dolby Laboratories (DLB): Exploring Valuation as Shares Recover from Tougher Stretch Earlier This Year

Simply Wall St.
·
Dec 02

Director Tony A. Prophet Reports Sale of Dolby Laboratories Inc. Common Shares

Reuters
·
Nov 27

Dolby Laboratories SVP John D. Couling Reports Sale of Common Shares

Reuters
·
Nov 25

CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference

GlobeNewswire
·
Nov 24

Research Reports -- Barrons.com

Dow Jones
·
Nov 22

Dolby Laboratories Navigates Complex Tech Standards Amid Shifting Broadcast and Internet Landscapes

TIPRANKS
·
Nov 20

BUZZ-U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet

Reuters
·
Nov 20

Dolby Partners with Bay Area Host Committee for Super Bowl LX Innovation Summit

Reuters
·
Nov 20

Dolby Laboratories Is Maintained at Outperform by Barrington Research

Dow Jones
·
Nov 19

Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating

MT Newswires Live
·
Nov 19

Dolby Laboratories Inc : Rosenblatt Securities Cuts Target Price to $85 From $95

THOMSON REUTERS
·
Nov 19

Strategic Advancements and Growth Potential Drive Buy Rating for Dolby Laboratories

TIPRANKS
·
Nov 19

BUZZ-Dolby down after holiday-quarter forecast misses estimates

Reuters
·
Nov 19

Rosenblatt Securities Reaffirms Their Buy Rating on Dolby Laboratories (DLB)

TIPRANKS
·
Nov 19

Dolby Laboratories Reports Strong Q4 2025 Financial Results

TIPRANKS
·
Nov 19

BRIEF-Dolby Laboratories Q4 Revenue USD 307 Million Vs. IBES Estimate USD 304.7 Million

Reuters
·
Nov 19